Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of relapsed or refractory acute myeloid leukemia patients failing venetoclax-based salvage therapies.
Zucenka A, Pileckyte R, Trociukas I, Peceliunas V, Vaitekenaite V, Maneikis K, Davainis L, Zvirblis T, Stoskus M, Gineikiene E, Norvilas R, Dirse V, Surauciute A, Zucenkiene E, Griskevicius L. Zucenka A, et al. Among authors: maneikis k. Eur J Haematol. 2021 Jan;106(1):105-113. doi: 10.1111/ejh.13527. Epub 2020 Oct 27. Eur J Haematol. 2021. PMID: 32997830
Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan.
Maneikis K, Ringeleviciute U, Bacevicius J, Dieninyte-Misiune E, Burokaite E, Kazbaraite G, Monika Janusaite M, Dapkeviciute A, Zucenka A, Peceliunas V, Kryzauskaite L, Kasiulevicius V, Ringaitiene D, Zablockiene B, Zvirblis T, Marinskis G, Jancoriene L, Griskevicius L. Maneikis K, et al. Int J Cardiol Heart Vasc. 2020 Dec 11;32:100685. doi: 10.1016/j.ijcha.2020.100685. eCollection 2021 Feb. Int J Cardiol Heart Vasc. 2020. PMID: 33335973 Free PMC article.
Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients.
Zucenka A, Maneikis K, Pugaciute B, Ringeleviciute U, Dapkeviciute A, Davainis L, Daukelaite G, Burzdikaite P, Staras V, Griskevicius L. Zucenka A, et al. Among authors: maneikis k. Ann Hematol. 2021 May;100(5):1195-1202. doi: 10.1007/s00277-021-04471-6. Epub 2021 Mar 4. Ann Hematol. 2021. PMID: 33661333 Free PMC article.
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K, Šablauskas K, Ringelevičiūtė U, Vaitekėnaitė V, Čekauskienė R, Kryžauskaitė L, Naumovas D, Banys V, Pečeliūnas V, Beinortas T, Griškevičius L. Maneikis K, et al. Lancet Haematol. 2021 Aug;8(8):e583-e592. doi: 10.1016/S2352-3026(21)00169-1. Epub 2021 Jul 2. Lancet Haematol. 2021. PMID: 34224668 Free PMC article.
Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation.
Zucenka A, Vaitekenaite V, Maneikis K, Davainis L, Pileckyte R, Trociukas I, Peceliunas V, Zvirblis T, Staras V, Griskevicius L. Zucenka A, et al. Among authors: maneikis k. Bone Marrow Transplant. 2021 Nov;56(11):2804-2812. doi: 10.1038/s41409-021-01416-5. Epub 2021 Jul 17. Bone Marrow Transplant. 2021. PMID: 34274954
Immunogenicity and clinical effectiveness of mRNA vaccine booster against SARS-CoV-2 Omicron in patients with haematological malignancies: A national prospective cohort study.
Kevličius L, Šablauskas K, Maneikis K, Juozapaitė D, Ringelevičiūtė U, Vaitekėnaitė V, Davainienė B, Daukėlaitė G, Vasilevska D, Stoškus M, Narkevičiūtė I, Sivickienė V, Rudaitis K, Minkauskas M, Naumovas D, Beinortas T, Griškevičius L. Kevličius L, et al. Among authors: maneikis k. Br J Haematol. 2024 Feb;204(2):497-506. doi: 10.1111/bjh.19126. Epub 2023 Oct 3. Br J Haematol. 2024. PMID: 37786970
11 results